Financials
- Market Capitalization 173.57 M
- Employee 97
- Founded 2011
- CEO N/A
- Website www.cariboubio.com
- Headquarter Delaware, United States
- FIGI BBG008G28LJ5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-1.34
Relación precio/flujo de caja
15.91
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 3711 | ACOG Alpha Cognition Inc. - Common Stock | 8.05 USD | 0.00% | -0.62% | +33.06% | -21.84% | 175.28 M USD | ||
| 3715 | EQ Equillium, Inc. - Common Stock | 2.74 USD | -0.72% | -8.67% | -2.84% | +602.56% | 173.24 M USD | ||
| 3727 | ANTX AN2 Therapeutics, Inc. - Common Stock | 4.60 USD | -3.36% | +11.65% | -6.69% | +333.96% | 165.67 M USD | ||
| 3730 | ADAG Adagene Inc - ADS, each representing 1.25 | 3.69 USD | +2.22% | -4.90% | +3.65% | +108.47% | 174.85 M USD |